Primary Site >> Stomach Cancer

Gene >> CIP2A

  • 2002
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2017
  • 2018
Ref: Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer.
PMID: 12118381
Ref: CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells.
PMID: 18559589
Ref: MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.
PMID: 19470954
Ref: Helicobacter pylori CagA upregulation of CIP2A is dependent on the Src and MEK/ERK pathways.
PMID: 19959630
Ref: KIAA1524: A novel MLL translocation partner in acute myeloid leukemia.
PMID: 20943269
Ref: Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression.
PMID: 21490338
Ref: Ets1 and Elk1 transcription factors regulate cancerous inhibitor of protein phosphatase 2A expression in cervical and endometrial carcinoma cells.
PMID: 23117818
Ref: CIP2A expression and prognostic role in patients with esophageal adenocarcinoma.
PMID: 23925667
Ref: Helicobacter pylori enhances CIP2A expression and cell proliferation via JNK2/ATF2 signaling in human gastric cancer cells.
PMID: 24398514
Ref: Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands.
PMID: 25015035
Ref: Relationship between CIP2A expression, and prognosis and MDR-related proteins in patients with advanced gastric cancer.
PMID: 26823836
Ref: Cucurbitacin B induces autophagy and apoptosis by suppressing CIP2A/PP2A/mTORC1 signaling axis in human cisplatin resistant gastric cancer cells.
PMID: 28534965
Ref: Oridonin induces apoptosis and reverses drug resistance in cisplatin resistant human gastric cancer cells.
PMID: 28781688
Ref: Increase in CIP2A expression is associated with cisplatin chemoresistance in gastric cancer.
PMID: 29103022
Ref: Polyphyllin I inhibits growth and invasion of cisplatin-resistant gastric cancer cells by partially inhibiting CIP2A/PP2A/Akt signaling axis.
PMID: 30119963